Replies to post #197899 on Cytodyn Inc (CYDY)

[Monroe1]

Of course they got a better deal. BP has made literally $Trillions$ so with all the cash it has to go somewhere. What better place than to buy off the company handling the trial data from a company that will put a huge dent into their bottom line and eliminate the need for shutdown. CytoDyn is not the only company to have such problems. This is how big big business operates. They don't deliver daiseys and lazy susans to your door and say welcome to the club. This is not the fist time Amarex has been in trouble. I want to know who talked the company into using them, and which other clinical trial management company was paid off to not work with CytoDyn. With the hundreds upon hundreds of companies applying to run trials, there most assuredly were huge backlogs and lots of competition for such services. When in the drivers seat not all options are good ones and someone has to make a decision. Go Nadaaaa, Happy New Year, Go Team Leronlimab. Good job despite the obstacles. 2022 the year the drug became world recognized.